BLZF2P

Across TCGA pan-cancer cohorts, BLZF2P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated BLZF2P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher BLZF2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BLZF2P expression acts as an unfavorable survival marker, although some lineages such as LAML and BRCA show a favorable association.

ACC, MESO, and LGG are the cancer types where BLZF2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.142	0.749	<.001	75	view →
MESO	OS	Median	All	0.404	0.646	.002	61	view →
LGG	DFS	Tertile	All	0.284	0.444	<.001	48	view →
READ	DFS	Tertile	All	0.293	0.634	<.001	47	view →
UVM	DFS	Tertile	II,III,IV	0.356	0.674	.009	36	view →
UCEC	DFS	Median	II,III,IV	0.747	0.860	.006	34	view →
LAML	DFS	Tertile	All	0.639	0.232	.008	30	view →
BLCA	DFS	Quartile	All	0.530	0.640	.014	27	view →
OV	DFS	Tertile	IV	0.219	0.496	.010	18	view →
THCA	OS	Tertile	III,IV	0.530	0.809	.023	18	view →
LIHC	DFS	Tertile	III,IV	0.165	0.479	.004	15	view →
BRCA	OS	Quartile	III,IV	0.929	0.804	.008	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

BLZF2P–ACC (OS)

Open the ACC breakdown →